PerkinElmer Divests Business; Increases Share Repurchase Program
August 31, 2010
PerkinElmer Divests Business; Increases Share Repurchase Program
The $500 million sale of its Illumination and Detection Solutions business will free up capital that can be reinvested in the firm's Human Health and Environmental Health businesses.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- GenMark Lowers Revenue Guidance after NMT, Luminex Deal
June 18, 2013 / GenomeWeb Daily News - Downloads and Upgrades: DNANexus' Developer Program, Active Infrastructure for HPC Life Sciences, and more
June 7, 2013 / BioInform - Paired Ends: Jay Therrien, Roger Schaller, Kevin Hrusovsky, Jim Corbett, Jonathan DeHart, More
May 21, 2013 / In Sequence - In Brief This Week: PerkinElmer, Verinata; Vermillion; DNA Genotek; Quest; More
May 17, 2013 / GenomeWeb Daily News - Illumina Names Several Partners for New TruSeq, Nextera Program
May 15, 2013 / GenomeWeb Daily News